A new possibility

• Author(s): Moita, Luís F. ; Sweeney, Timothy E. ; Povoa, Pedro
• Date: 2022
• Persistent ID: http://hdl.handle.net/10362/151439
• Origin: Repositório Institucional da UNL
• Subject(s): Critical Care and Intensive Care Medicine
• Document Type: Other
• Language: English
• Contributor(s): NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM); RUN

Description

Funding Information: LFM—None to declare. TES—employee of and shareholder in Inflammatix, Inc. PP—received fees for lecture from Gilead and Pfizer, consulting from MSD and Sanofi and unrestricted research grant from Abionic.